Research Article
Healthy lifestyle, endoscopic screening, and colorectal cancer incidence and mortality in the United States: A nationwide cohort study
Kai Wang, Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America Roles Formal analysis, Methodology, Project administration, Software, Writing – review & editing
Affiliations Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America, Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America
Jan 22, 2021
THURSDAY, Jan. 21, 2021 (HealthDay News) Regular use of aspirin is associated with a reduced risk for colorectal cancer (CRC) among those with initiation of aspirin before age 70 years, according to a study published online Jan. 21 in
JAMA Oncology.
Chuan Guo-Guo, M.Med., from Massachusetts General Hospital in Boston, and colleagues examined the correlation between aspirin use and risk for incident CRC among older adults in a pooled analysis conducted using the Nurses’ Health Study and the Health Professionals Follow-up Study. Data were included for 94,540 participants aged 70 years or older.
The researchers identified 1,431 incident cases of CRC during 996,463 person-years of follow-up. Compared with nonregular use, regular use of aspirin was associated with a significantly reduced risk for CRC at or after age 70 years after adjustment for other risk factors (hazard ratio, 0.80; 95 percent confidence interval, 0.72 to 0.90). The inverse association was only see
Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long?
There is substantial evidence that a daily aspirin can reduce risk of colorectal cancer in adults up to age 70. But until now there was little evidence about whether older adults should start taking aspirin.
A team of scientists set out to study this question. They were led by Andrew T. Chan, a professor of medicine at Harvard Medical School and gastroenterologist and chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital (MGH). Their report appears in JAMA Oncology.
E-Mail
BOSTON - Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long?
There is substantial evidence that a daily aspirin can reduce risk of colorectal cancer in adults up to age 70. But until now there was little evidence about whether older adults should start taking aspirin.
A team of scientists set out to study this question. They were led by Andrew T. Chan MD, MPH, a gastroenterologist and chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital (MGH). Their report appears in
More Fruits and Veggies Could Prevent Millions of Cardiovascular Deaths
Mounting research affirms the crucial role proper diet and nutrition play in preventing the most common causes of death
Low fruit and vegetable intake may be a major factor in heart disease deaths. Findings from a 2019 study found low fruit intake translated to almost 1.8 million cardiovascular deaths in 2010 while low vegetable consumption resulted in 1 million deaths. The cardiovascular impact of low fruit and vegetable consumption were most acute in countries with the lowest average consumption of fruits and vegetables.
Let’s have a closer look at the different factors that drive these findings and how you can optimize your fruit and veggie intake for a healthy, thriving heart.